In contrast, in the anti‐ACE2‐IgM‐negative group, 13 patients had HRCT imaging within 3 months of blood draw and 10 of 13 (77%) had evidence of ILD (P = 0.52). The gene discussed is ACE2; the disease is interstitial lung disease.